Table 1.
Demographics and clinical characteristics of maternal and neonatal cohort included in the AMANHI biorepository.
Table 2.
Distribution of dried blood spot amino acids, acylcarnitines and succinylacetone concentrations in neonates included in AMANHI study.
Fig 1.
Gender wise distribution of DBS biomarkers in cohort of neonates from AMANHI biorepository.
a: Gender wise distribution of DBS amino acid and succinylacetone concentrations in cohort of neonates from AMANHI biorepository in Pakistan (n = 610). b: Gender wise distribution of DBS acylcarnitine in cohort of neonates from AMANHI biorepository in Pakistan (n = 610).
Table 3.
Relative difference in amino acids, succinylacetone and acylcarnitine concentrations between term groups and gestational age in dried blood spot of neonates from AMANHI study.
Fig 2.
Age wise distribution of DBS biomarkers according to age in cohort of neonates from AMANHI bio repository in Pakistan (n = 610).
a: Age wise distribution of DBS amino acid and succinylacetone concentrations according in age of neonates from AMANHI bio repository in Pakistan (n = 610). b: Age wise distribution of DBS acylcarnitine concentrations according to age of neonates from AMANHI bio repository in Pakistan (n = 610).